Clinical Trials

48 enrolled

Breast

Breast Neoplasms

NCT06120283 2026-05-27

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

399 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT06132113 2026-05-27

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

55 enrolled

Endocrine

Neuroendocrine Neoplasms

NCT06248411 2026-05-27

A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors

189 enrolled

Advanced or Metastatic Solid Tumors

NCT06458712 2026-05-27

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

180 enrolled

CNS

Kenny-Caffey syndrome, Type 1, Anophthalmia with pulmonary hypoplasia, Brain Neoplasms

NCT06714591 2026-05-27

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

Other hematologic neoplasm

120 enrolled

Leukemia, Myeloid, Acute

NCT07073547 2026-05-27

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

40 enrolled

Plasma cell

Multiple Myeloma

NCT07226349 2026-05-27

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

105 enrolled

Advanced Solid Tumor

NCT07306559 2026-05-27

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

187 enrolled

Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT07407504 2026-05-27

GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.

186 enrolled

Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated

NCT07414836 2026-05-27

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

84 enrolled

Advanced Solid Tumor

NCT07438782 2026-05-27

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

97 enrolled

Neoplasms

NCT07604571 2026-05-27

Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

194 enrolled

Breast

Advanced HR+/HER2- Breast Cancer

NCT07607678 2026-05-27

A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

60 enrolled

Unresectable Advanced or Metastatic Solid Cancer

NCT04929223 2026-05-26

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

542 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05067283 2026-05-26

KANDLELIT-001

830 enrolled

Advanced Solid Tumors

NCT06147037 2026-05-26

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

GastrointestinalGenitourinaryHead & NeckThoracic

70 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Stomach Neoplasms, Colorectal Neoplasms

NCT06492122 2026-05-26

ProTACT

50 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT06596473 2026-05-26

A Study of BG-C477 in Participants With Advanced Solid Tumors

310 enrolled

Advanced Solid Tumors

NCT07128303 2026-05-26

Study of GS-5319 in Adults With Solid Tumors

178 enrolled

Advanced Solid Tumor

NCT07181681 2026-05-26

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

63 enrolled

Solid Tumors

NCT07226427 2026-05-26

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

100 enrolled

Gynecologic

Ovarian Neoplasms

NCT07572006 2026-05-26

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

Other hematologic neoplasm

280 enrolled

Hematologic Neoplasms

NCT03715933 2026-05-22

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

411 enrolled

Sarcoma

Sarcoma, Sarcoma, Ewing

NCT05362773 2026-05-22

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

LymphoidMyeloidOther hematologic neoplasm

130 enrolled

Blastic Plasmacytoid Dendritic Cell Neoplasm, Leukemia, Hairy Cell, Myelodysplastic Syndromes, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Mastocytosis, Systemic

NCT05464030 2026-05-22

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

200 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05981703 2026-05-22

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

217 enrolled

Advanced Solid Tumor

NCT06115642 2026-05-22

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors

367 enrolled

Advanced/Metastatic Malignant Solid Tumors

NCT06215118 2026-05-22

MagnetisMM-30

87 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT06431594 2026-05-22

BEHOLD-1

675 enrolled

Neoplasms

NCT06465069 2026-05-22

NEXUS-01

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

420 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Ureteral Neoplasms, Urologic Neoplasms, Triple Negative Breast Neoplasms

NCT06551142 2026-05-22

PanTumor-101

845 enrolled

Neoplasms

NCT06589596 2026-05-22

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

525 enrolled

Advanced Solid Tumor

NCT06598800 2026-05-22

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

153 enrolled

Advanced Solid Tumor

NCT06789172 2026-05-22

INVOKE

GastrointestinalHead & NeckSarcomaThoracic

166 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Liposarcoma, Sarcoma, Colorectal Neoplasms, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT06803680 2026-05-22

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

90 enrolled

Neoplasm Metastasis

NCT07080242 2026-05-22

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

120 enrolled

Endocrine

Carcinoma, Neuroendocrine

NCT07114601 2026-05-22

OMNIRAY

BreastGastrointestinalGenitourinaryGynecologic

421 enrolled

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07189403 2026-05-22

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

40 enrolled

Endocrine

Adrenocortical Carcinoma

NCT07213791 2026-05-22

FiREBOLT

BreastGastrointestinalGynecologic

241 enrolled

Pancreatic Intraductal Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT07311993 2026-05-22

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

60 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07403721 2026-05-22

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

464 enrolled

Neoplasm Metastasis

NCT07477587 2026-05-22

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

258 enrolled

Plasma cell

Multiple Myeloma

NCT07531095 2026-05-22

DeLLphi-313

160 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07578571 2026-05-22

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

BreastGastrointestinalThoracic

175 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT03460977 2026-05-20

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

453 enrolled

LymphoidThoracic

Lymphoma, Follicular, Recurrence, Small Cell Lung Carcinoma

NCT05538130 2026-05-20

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

CNSDermatologicHead & NeckThoracic

124 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioma, Melanoma, Neoplasms, Thyroid Neoplasms

NCT06673017 2026-05-20

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

26 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06966024 2026-05-20

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers